Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)

  • Marnix Lameijer
  • , Tina Binderup
  • , Mandy M.T. van Leent
  • , Max L. Senders
  • , Francois Fay
  • , Joost Malkus
  • , Brenda L. Sanchez-Gaytan
  • , Abraham J.P. Teunissen
  • , Nicolas Karakatsanis
  • , Philip Robson
  • , Xianxiao Zhou
  • , Yuxiang Ye
  • , Gregory Wojtkiewicz
  • , Jun Tang
  • , Tom T.P. Seijkens
  • , Jeffrey Kroon
  • , Erik S.G. Stroes
  • , Andreas Kjaer
  • , Jordi Ochando
  • , Thomas Reiner
    • Carlos Pérez-Medina, Claudia Calcagno, Edward A. Fisher, Bin Zhang, Ryan E. Temel, Filip K. Swirski, Matthias Nahrendorf, Zahi A. Fayad, Esther Lutgens, Willem J.M. Mulder, Raphaël Duivenvoorden

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Fingerprint

Dive into the research topics of 'Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2)'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology